Single Cell RNA Profiling of Circulating Tumor Cells in Patients With Prostate Cancer
David T. Miyamoto(Broad Institute), Daniel A. Haber(Howard Hughes Medical Institute), David T. Ting(Massachusetts General Hospital), Ravi Kapur(Harvard University), Katherine Broderick(Harvard University), Kshitij S. Arora(Louisiana State University Health Sciences Center Shreveport), Chin‐Lee Wu(Massachusetts General Hospital), Leica V. Sequist(Massachusetts General Hospital), Brian W. Brannigan(Harvard University), R.J. Lee(Massachusetts General Hospital), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), Yu Zheng(Howard Hughes Medical Institute), Matthew R. Smith(Harvard University), Huili Zhu(Yantai University), Rooma Desai(Massachusetts General Hospital), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), Douglas M. Dahl(Harvard University)
International Journal of Radiation Oncology*Biology*Physics
October 17, 2015
Cited by 3
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k